PMV Pharmaceuticals News and Activities
Presence
Headquarters: United States (USA)
PMV Pharmaceuticals is a company listed under the stock ticker PMVP (US).
Executives
View the org chart displaying its 21 main executives
Most searched biographies at PMV Pharmaceuticals
- David Mack, Director, President and Chief Executive Officer
- Laurie Stelzer, Chairman of the Board
- Arnold Levine, Director
Popular executive movements at PMV Pharmaceuticals
- Laurie Stelzer will join the company as Chairman of the Board on Jun. 4, 2026 (posted on April 22 2026).
- Richard Heyman, Chairman of the Board, will leave the company on Jun. 4, 2026 (posted on April 22 2026).
- Laura De Leon, who was Vice President and Head of Clinical Operations, is promoted to Vice President, Clinical Development Operations (posted on April 22 2026).
Create your alert
to follow the executive moves at PMV Pharmaceuticals.
Pharmaceuticals
PMV Pharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by PMV Pharmaceuticals
- PMV Pharmaceuticals Announces a Clinical Trial Collaboration with Merck to Evaluate PC14586 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Initial PC14586 Phase 1 Data Presented at ASCO Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a p53 Y220C Mutation | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Announces Initial PC14586 Phase 1 Clinical Data to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Reports First Quarter 2022 Financial Results and Corporate Highlights | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Present PC14586 Phase 1 Clinical Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Participate in the 42nd Annual Cowen Health Care Conference | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Participate in the Guggenheim Healthcare Talks 2022 Oncology Day | PMV Pharmaceuticals, Inc.
- PMV Pharma Announces Changes to its Board of Directors | PMV Pharmaceuticals, Inc.
- View more press releases Close
Social media about PMV Pharmaceuticals
- PMV Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- PMV Pharmaceuticals on LinkedIn, X (Twitter) & YouTube
